genomic datasets Streamline Genomics Looks to Expand Variant Analysis Offering With Free Search, Paid Analytics Premium The Montreal startup wants its informatics technology to help make precision medicine ubiquitous on the front lines of treatment. European Project Aims to Integrate COVID-19 Genomics, Public Health, Social Sciences Data Premium The €12 million European Union-backed effort, called BeYond-COVID, commenced last month and will run through October 2024. Genomenon, Inozyme Collaborate on MDx Effort for ENPP1 Deficiency The companies hope to deliver AI-powered data to labs and clinicians to diagnose and treat a rare calcification disorder. Partnership Aims to Sequence African Genomes in Fight for Health Equity Premium Startups HelaPlex and IndyGeneUS are creating a secure genomic database to create more diversity in drug development as they fight to compensate the Lacks family. Data Privacy Concerns Top of Mind for Planned African Genome Project Premium As organizers develop a plan to sequence 3 million genomes across Africa, bioinformaticians weigh the benefits and risks of such a large, diverse dataset. Jul 28, 2021 AbbVie, Biogen, Pfizer Join With Broad Institute on Genebass Exome Variant Project Premium May 7, 2021 Seven Bridges, ZS Partner for Multiomics Analytics in Drug Development Mar 17, 2021 M2Gen Lands New Private Investment, Inks Research Deal with Merck Mar 2, 2021 NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program Jan 29, 2021 4HF Biotec Banking on Multiomic Data Analysis to Help Pharma Find New Oncology Compounds Premium Jan 27, 2021 One Codex, Transnetyx Collaborate on Microbiome Sequencing and Analysis Services Jan 22, 2021 Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease Premium Jan 11, 2021 Adaptive Biotechnologies, AstraZeneca Collaborate on Mapping Immune Response in Cancer Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Dec 23, 2020 AnVIL Platform Makes Popular NHGRI GTEx Database Free to Download Premium Dec 21, 2020 Adaptive Biotechnologies, Q2 Solutions Sign Marketing Agreement for ImmunoSeq Assay Dec 15, 2020 Life Sciences Software Company Nference Completes $60M Series C Funding Round Nov 10, 2020 Genosity, Igentify Collaborate on Genetic Counseling Software, Ink Comarketing Deal Oct 28, 2020 Q&A: NHGRI's Eric Green on Advancements and Ongoing Challenges in Genomics Premium Oct 15, 2020 Pacific Biosciences, Children's Mercy, Microsoft Collaborate on Rare Genetic Disease Diagnostics Oct 8, 2020 Pacific Biosciences' New Sequel IIe System Puts Focus on High Read Accuracy Premium Oct 7, 2020 University of Manchester, Sano Genetics to Research Eye Diseases Oct 2, 2020 Demand Grows for Chief Research Information Officers as Role Evolves Along With Data Types Premium Oct 1, 2020 Genuity Science, Ionis Pharmaceuticals Partner on Antisense Therapy Development Sep 23, 2020 Center for Genomic Regulation's COVID-19 Viral Beacon Digs Into Thousands of SARS-CoV-2 Genomes Premium Load More Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.